Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Single-cell transcriptomics of alloreactive CD4+ T cells over time reveals divergent fates during gut graft-versus-host disease
Jessica A. Engel, Hyun Jae Lee, Cameron G. Williams, Rachel Kuns, Stuart Olver, Lianne I.M. Lansink, Megan S.F. Soon, Stacey B. Andersen, Joseph E. Powell, Valentine Svensson, Sarah A. Teichmann, Geoffrey R. Hill, Antiopi Varelias, Motoko Koyama, Ashraful Haque
Jessica A. Engel, Hyun Jae Lee, Cameron G. Williams, Rachel Kuns, Stuart Olver, Lianne I.M. Lansink, Megan S.F. Soon, Stacey B. Andersen, Joseph E. Powell, Valentine Svensson, Sarah A. Teichmann, Geoffrey R. Hill, Antiopi Varelias, Motoko Koyama, Ashraful Haque
View: Text | PDF
Research Article Hematology Immunology

Single-cell transcriptomics of alloreactive CD4+ T cells over time reveals divergent fates during gut graft-versus-host disease

  • Text
  • PDF
Abstract

Acute gastrointestinal (GI) graft-versus-host disease (GVHD) is a primary determinant of mortality after allogeneic hematopoietic stem cell transplantation (alloSCT). The condition is mediated by alloreactive donor CD4+ T cells that differentiate into pathogenic subsets expressing IFN-γ, IL-17A, or GM-CSF and is regulated by subsets expressing IL-10 and/or Foxp3. Developmental relationships between Th cell states during priming in mesenteric lymph nodes (mLNs) and effector function in the GI tract remain undefined at genome scale. We applied scRNA-Seq and computational modeling to a mouse model of donor DC-mediated GVHD exacerbation, creating an atlas of putative CD4+ T cell differentiation pathways in vivo. Computational trajectory inference suggested emergence of pathogenic and regulatory states along a single developmental trajectory in mLNs. Importantly, we inferred an unexpected second trajectory, categorized by little proliferation or cytokine expression, reduced glycolysis, and high tcf7 expression. TCF1hi cells upregulated α4β7 before gut migration and failed to express cytokines. These cells exhibited recall potential and plasticity following secondary transplantation, including cytokine or Foxp3 expression, but reduced T cell factor 1 (TCF1). Thus, scRNA-Seq suggested divergence of alloreactive CD4+ T cells into quiescent and effector states during gut GVHD exacerbation by donor DC, reflecting putative heterogeneous priming in vivo. These findings, which are potentially the first at a single-cell level during GVHD over time, may assist in examination of T cell differentiation in patients undergoing alloSCT.

Authors

Jessica A. Engel, Hyun Jae Lee, Cameron G. Williams, Rachel Kuns, Stuart Olver, Lianne I.M. Lansink, Megan S.F. Soon, Stacey B. Andersen, Joseph E. Powell, Valentine Svensson, Sarah A. Teichmann, Geoffrey R. Hill, Antiopi Varelias, Motoko Koyama, Ashraful Haque

×

Figure 1

Alloreactive donor CD4+ TEa T cells acquire proinflammatory and regulatory states during acute GVHD exacerbation.

Options: View larger image (or click on image) Download as PowerPoint
Alloreactive donor CD4+ TEa T cells acquire proinflammatory and regulato...
(A) Schematic for model of acute gut-mediated GVHD exacerbation where donor CD4+ T cells respond to host allogeneic peptide presented within donor MHC class II, which in turn drives CD4+ T cell expansion in the mesenteric lymph node (mLN). (B and C) Representative FACS plots for IFN-γ and IL-17A production and Foxp3 expression on TEa cells from the mLN at day 4 after transfer, with PMA/ionomycin restimulation (B) or directly ex vivo (C). Graphs represent IFN-γ+, IL-17A+, or Foxp3+ TEa cell percentages. Data shown are combined from 3 replicate experiments (n = 10 mice) and are represented as box-and-whisker plots, with bounds from 25th to 75th percentile, median line, and whiskers ranging from minimum to maximum values. Statistical analysis was performed between the isotype control (ISO) and respective cytokine samples using a Mann-Whitney U test. **P ≤ 0.01. GVHD, graft-versus-host disease.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts